Is there an upper age limit for bone marrow transplantation?

被引：32

作者：

Popplewell, LL ^{[1
]}

Forman, SJ ^{[1
]}

机构：

[1] City Hope Comprehens Canc Ctr, Div Hematol & Bone Marrow Transplantat, Duarte, CA USA

来源：

BONE MARROW TRANSPLANTATION | 2002年 / 29卷 / 04期

关键词：

patient age; mortality; survival; GVHD; transplant; non-myeloablative;

D O I：

10.1038/sj.bmt.1703382

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

Advances in hematopoietic cell transplantation have reduced the toxicity of both allogeneic and autologous transplantation. Decisions regarding the feasibility of transplantation should be individualized, and based upon physiological rather than chronological age.

引用

页码：277 / 284

页数：8

共 53 条

[1]

ASCHAN J, 1994, CLIN TRANSPLANT, V8, P258

[2]

ATKINSON K, 1990, BLOOD, V75, P2459

[3] A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma [J].

Attal, M ;

Harousseau, JL ;

Stoppa, AM ;

Sotto, JJ ;

Fuzibet, JG ;

Rossi, JF ;

Casassus, P ;

Maisonneuve, H ;

Facon, T ;

Ifrah, N ;

Payen, C ;

Bataille, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (02) :91-97

[4] Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years [J].

Badros, A ;

Barlogie, B ;

Siegel, E ;

Morris, C ;

Desikan, R ;

Zangari, M ;

Fassas, A ;

Anaissie, E ;

Munshi, N ;

Tricot, G .

BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (03) :600-607

[5] Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. [J].

Bensinger, WI ;

Martin, PJ ;

Storer, B ;

Clift, R ;

Forman, SJ ;

Negrin, R ;

Kashyap, A ;

Flowers, MED ;

Lilleby, K ;

Chauncey, TR ;

Storb, R ;

Appelbaum, FR ;

Rowley, S ;

Heimfeld, S ;

Blume, K .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (03) :175-181

[6]

Bloomfield CD, 1998, CANCER RES, V58, P4173

[7] BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES IN PATIENTS AGED 30 YEARS OR OLDER [J].

BLUME, KG ;

FORMAN, SJ ;

NADEMANEE, AP ;

ODONNELL, MR ;

SNYDER, DS ;

FAHEY, JL ;

SNIECINSKI, IJ ;

FINDLEY, DO ;

LIPSETT, JA ;

ZAIA, JA ;

METTER, GE ;

HILL, LR .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (10) :1489-1492

[8] AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR FIRST REMISSION ACUTE MYELOBLASTIC-LEUKEMIA IN PATIENTS OLDER THAN 50 YEARS - A RETROSPECTIVE ANALYSIS OF THE EUROPEAN-BONE-MARROW-TRANSPLANT-GROUP [J].

CAHN, JY ;

LABOPIN, M ;

MANDELLI, F ;

GOLDSTONE, AH ;

EBERHARDT, K ;

REIFFERS, J ;

FERRANT, A ;

FRANKLIN, I ;

HERVE, P ;

GRATWOHL, A ;

GORIN, NC .

BLOOD, 1995, 85 (02) :575-579

[9] Risk factors for chronic graft-versus-host disease after bone marrow transplantation:: a retrospective single centre analysis [J].

Carlens, S ;

Ringdén, O ;

Remberger, M ;

Lönnqvist, B ;

Hägglund, H ;

Klaesson, S ;

Mattsson, J ;

Svahn, BM ;

Winiarski, J ;

Ljungman, P ;

Aschan, J .

BONE MARROW TRANSPLANTATION, 1998, 22 (08) :755-761

[10]

CLIFT RA, 1993, BLOOD, V82, P1954

← 1 2 3 4 5 6 →